Cerebral amyloid angiopathy (CAA) often presents as cognitive impairment, but the mechanism of cognitive decline is unclear. Recent studies showed that number of microbleeds were associated with cognitive decline.
Objective:
We aimed to investigate how microbleeds contribute to cognitive impairment in association with white matter tract abnormalities or cortical thickness in CAA.
Methods:
This retrospective comparative study involved patients with probable CAA according to the Boston criteria (Aβ+ CAA) and patients with Alzheimer’s disease (Aβ+ AD), all of whom showed severe amyloid deposition on amyloid PET. Using mediation analysis, we investigated how FA or cortical thickness mediates the correlation between the number of lobar microbleeds and cognition.
Results:
We analyzed 30 patients with Aβ+ CAA (age 72.2±7.6, female 53.3%) and 30 patients with Aβ+ AD (age 71.5±7.6, female 53.3%). The two groups showed similar degrees of cortical amyloid deposition in AD-related regions. The Aβ+ CAA group had significantly lower FA values in the clusters of the posterior area than did the Aβ+ AD group
(family-wise error-corrected p < 0.05). The correlation between the number of lobar microbleeds and visuospatial function was indirectly mediated by white matter tract abnormality of right posterior thalamic radiation (PTR) and tapetum, while lobar microbleeds and language function was indirectly mediated by the abnormality of left PTR and sagittal stratum. Cortical thickness did not mediate the association between lobar microbleeds and cognition.
Conclusion:
This result supports the hypothesis that microbleeds burden leads to white matter tract damage and subsequent cognitive decline in CAA.
AkoudadS, WoltersFJ, ViswanathanA, de BruijnRF, van der LugtA, HofmanA, KoudstaalPJ, IkramMA, VernooijMW (2016) Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol73, 934–943.
6.
PoelsMM, IkramMA, van der LugtA, HofmanA, NiessenWJ, KrestinGP, BretelerMM, VernooijMW (2012) Cerebral microbleeds are associated with worse cognitive function: The Rotterdam Scan Study. Neurology78, 326–333.
7.
LeiC, LinS, TaoW, HaoZ, LiuM, WuB (2013) Association between cerebral microbleeds and cognitive function: A systematic review. J Neurol Neurosurg Psychiatry84, 693–697.
8.
LiuJY, ZhouYJ, ZhaiFF, HanF, ZhouLX, NiJ, YaoM, ZhangS, JinZ, CuiL, ZhuYC (2020) Cerebral microbleeds are associated with loss of white matter integrity. AJNR Am J Neuroradiol41, 1397–1404.
9.
JangH, JangYK, KimHJ, WerringDJ, LeeJS, ChoeYS, ParkS, LeeJ, KimKW, KimY, ChoSH, KimSE, KimSJ, CharidimouA, NaDL, SeoSW (2019) Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers. Eur J Nucl Med Mol Imaging46, 1287–1298.
10.
FotiadisP, ReijmerYD, Van VeluwSJ, Martinez-RamirezS, KarahanogluFI, GokcalE, SchwabKM, Alzheimer’s Disease Neuroimaging Initiative study group, GoldsteinJN, RosandJ, ViswanathanA, GreenbergSM, GurolME (2020) White matter atrophy in cerebral amyloid angiopathy. Neurology95, e554–e562.
11.
AhnSJ, AnratherJ, NishimuraN, SchafferCB (2018) Diverse inflammatory response after cerebral microbleeds includes coordinated microglial migration and proliferation. Stroke49, 1719–1726.
12.
GreenbergSM, CharidimouA (2018) Diagnosis of cerebral amyloid angiopathy: Evolution of the Boston criteria. Stroke49, 491–497.
13.
BarthelH, GertzHJ, DreselS, PetersO, BartensteinP, BuergerK, HiemeyerF, Wittemer-RumpSM, SeibylJ, ReiningerC, SabriO, Florbetaben Study Group (2011) Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer’s disease and healthy controls: A multicentre phase 2 diagnostic study. Lancet Neurol10, 424–435.
14.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr., KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
15.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
16.
KangY, NaD (2003) Seoul neuropsychological screening battery (SNSB), Human Brain Research & Consulting Co, Incheon.
17.
SonHJ, OhJS, RohJH, SeoSW, OhM, LeeSJ, OhSJ, KimJS (2019) Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias. Eur J Nucl Med Mol Imaging46, 357–366.
18.
HaackeEM, MittalS, WuZ, NeelavalliJ, ChengYC (2009) Susceptibility-weighted imaging: Technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol30, 19–30.
19.
KimJE, KimSW, ChoiM, SeongJK, LeeJH (2019) Identifying brain connectivity using network-based statistics in amnestic mild cognitive impairment stratified by β-amyloid positivity. Am J Alzheimers Dis Other Demen34, 104–111.
CuiZ, ZhongS, XuP, HeY, GongG (2013) PANDA: A pipeline toolbox for analyzing brain diffusion images. Front Hum Neurosci7, 42.
22.
AnderssonJLR, SotiropoulosSN (2016) An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage125, 1063–1078.
SmithSM, JenkinsonM, WoolrichMW, BeckmannCF, BehrensTE, Johansen-BergH, BannisterPR, De LucaM, DrobnjakI, FlitneyDE, NiazyRK, SaundersJ, VickersJ, ZhangY, De StefanoN, BradyJM, MatthewsPM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage23, S208–219.
26.
MoriS, WakanaS, van ZijlPCM, Nagae-PoetscherLM (2005) MRI atlas of human white matter, Elsevier Science, Amsterdam.
27.
FazekasF, KleinertR, OffenbacherH, SchmidtR, KleinertG, PayerF, RadnerH, LechnerH (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology43, 1683–1689.
28.
WardlawJM, SmithEE, BiesselsGJ, CordonnierC, FazekasF, FrayneR, LindleyRI, O’BrienJT, BarkhofF, BenaventeOR, BlackSE, BrayneC, BretelerM, ChabriatH, DecarliC, de LeeuwFE, DoubalF, DueringM, FoxNC, GreenbergS, HachinskiV, KilimannI, MokV, OostenbruggeR, PantoniL, SpeckO, StephanBC, TeipelS, ViswanathanA, WerringD, ChenC, SmithC, van BuchemM, NorrvingB, GorelickPB, DichgansM, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1) (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol12, 822–838.
29.
ChengAL, BatoolS, McCrearyCR, LauzonML, FrayneR, GoyalM, SmithEE (2013) Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke44, 2782–2786.
30.
GreenbergSM, VernooijMW, CordonnierC, ViswanathanA, Al-Shahi SalmanR, WarachS, LaunerLJ, Van BuchemMA, BretelerMM, Microbleed Study Group (2009) Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol8, 165–174.
31.
CharidimouA, LinnJ, VernooijMW, OpherkC, AkoudadS, BaronJC, GreenbergSM, JägerHR, WerringDJ (2015) Cortical superficial siderosis: Detection and clinical significance in cerebral amyloid angiopathy and related conditions. Brain138, 2126–2139.
32.
VanderWeeleTJ (2015) Explanation in causal inference: Methods for mediation and interaction, Oxford University Press, New York, NY.
33.
CharidimouA, FaridK, TsaiHH, TsaiLK, YenRF, BaronJC (2018) Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: A systematic review and meta-analysis of biomarker performance. J Neurol Neurosurg Psychiatry89, 410–417.
34.
KimJP, KimJ, KimY, MoonSH, ParkYH, YooS, JangH, KimHJ, NaDL, SeoSW, SeongJK (2020) Staging and quantification of florbetaben PET images using machine learning: Impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes. Eur J Nucl Med Mol Imaging47, 1971–1983.
35.
ParkJH, SeoSW, KimC, KimGH, NohHJ, KimST, KwakKC, YoonU, LeeJM, LeeJW, ShinJS, KimCH, NohY, ChoH, KimHJ, YoonCW, OhSJ, KimJS, ChoeYS, LeeKH, LeeJH, EwersM, WeinerMW, WerringDJ, NaDL (2013) Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol73, 584–593.
36.
FazekasF, KleinertR, RoobG, KleinertG, KapellerP, SchmidtR, HartungHP (1999) Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: Evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol20, 637–642.
37.
FotiadisP, van RoodenS, van der GrondJ, SchultzA, Martinez-RamirezS, AurielE, ReijmerY, van OpstalAM, AyresA, SchwabKM, Alzheimer’s Disease Neuroimaging Initiative (ADNI), HeddenT, RosandJ, ViswanathanA, WermerM, TerwindtG, SperlingRA, PolimeniJR, JohnsonKA, van BuchemMA, GreenbergSM, GurolME (2016) Cortical atrophy in patients with cerebral amyloid angiopathy: A case-control study. Lancet Neurol15, 811–819.
38.
LiuM, NieZY, LiRR, ZhangW, WangH, HeYS, ZhaoLJ, LiYX (2018) Correlation of brain perfusion with white matter hyperintensity, brain atrophy, and cognition in patients with posterior cerebral artery stenosis and subjective cognitive decline. Med Sci Monit24, 5729–5738.
39.
SotakCH (2002) The role of diffusion tensor imaging in the evaluation of ischemic brain injury - a review. NMR Biomed15, 561–569.
40.
FrielingH, FischerJ, WilhelmJ, EngelhornT, BleichS, HillemacherT, DörflerA, KornhuberJ, de ZwaanM, PeschelT (2012) Microstructural abnormalities of the posterior thalamic radiation and the mediodorsal thalamic nuclei in females with anorexia nervosa –a voxel based diffusion tensor imaging (DTI) study. J Psychiatr Res46, 1237–1242.
41.
SarikciogluL, OzsoyU, UnverG (2007) Tapetum corporis callosi: Carpet of the brain. J Hist Neurosci16, 432–434.
42.
GoldmanJG, BledsoeIO, MerkitchD, DinhV, BernardB, StebbinsGT (2017) Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease. Neurology88, 1265–1272.
43.
ZarkaliA, McColganP, LeylandLA, LeesAJ, WeilRS (2021) Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson’s disease. Mov Disord36, 1191–1202.
44.
KurzawskiJW, MikellidouK, MorroneMC, PestilliF (2020) The visual white matter connecting human area prostriata and the thalamus is retinotopically organized. Brain Struct Funct225, 1839–1853.
45.
TakemuraH, Palomero-GallagherN, AxerM, GräßelD, JorgensenMJ, WoodsR, ZillesK (2020) Anatomy of nerve fiber bundles at micrometer-resolution in the vervet monkey visual system. eLife9, 55444.
46.
GeorgeK, JMD, Neuroanatomy, thalamocortical radiations. In StatPearls [Internet], StatPearls Publishing, Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK546699, Last updated 31 July, 2020, Accessed April 30, 2021.
47.
Di CarloDT, BenedettoN, DuffauH, CagnazzoF, WeissA, CastagnaM, CosottiniM, PerriniP (2019) Microsurgical anatomy of the sagittal stratum. Acta Neurochir (Wien)161, 2319–2327.
48.
DickAS, TremblayP (2012) Beyond the arcuate fasciculus: Consensus and controversy in the connectional anatomy of language. Brain135, 3529–3550.
49.
CharidimouA, Martinez-RamirezS, ShoamaneshA, Oliveira-FilhoJ, FroschM, VashkevichA, AyresA, RosandJ, GurolME, GreenbergSM, ViswanathanA (2015) Cerebral amyloid angiopathy with and without hemorrhage: Evidence for different disease phenotypes. Neurology84, 1206–1212.
